SCHEMBL3744044

SCHEMBL3744044

O=C1OC=CC1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1477646 0.69
SCHEMBL1856117 0.67
SCHEMBL31649405 0.67
SCHEMBL122103 0.67
Bromide SCHEMBL2745855 0.65
SCHEMBL31092010 0.65
SCHEMBL10898470 0.63
Cyclopropane SCHEMBL665011 0.62
SCHEMBL13817748 0.62
SCHEMBL7341958 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560932-B1 PROCESS FOR PREPARING 7H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND SYNTHETIC INTERMEDIATES OF SAME JAPAN TOBACCO INC (JP) 2026-03-11 EP disclosed
US-20250084106-A1 PROCESS FOR PREPARING 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES AND SYNTHETIC INTERMEDIATES THEREOF LEO PHARMA A/S (DK) 2025-03-13 US disclosed
US-12195481-B2 Process for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and synthetic intermediates thereof JAPAN TOBACCO INC. (JP) 2025-01-14 US disclosed
US-20240140967-A1 PROCESS FOR PREPARING 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES AND SYNTHETIC INTERMEDIATES THEREOF LEO PHARMA A/S (DK) 2024-05-02 US disclosed
CN-117865992-A Process for preparing 7H-pyrrolo [2,3-d ] pyrimidine derivatives and synthetic intermediates therefor 日本烟草产业株式会社 2024-04-12 CN disclosed
CN-113957004-B Flavobacterium aureum and application thereof in preparation of halophyte epiphyte repair maintenance microbial inoculum 中国科学院烟台海岸带研究所 2024-02-20 CN disclosed
CN-114615890-B Herbicidal mixtures comprising aminopyridine and quinic acid 安道麦阿甘有限公司 2024-02-13 CN disclosed
CN-110300756-B Process for preparing 7H-pyrrolo [2,3-d ] pyrimidine derivatives and synthetic intermediates therefor 日本烟草产业株式会社 2024-01-02 CN disclosed
CN-112236421-B Pyrazole derivatives and pest control agents 组合化学工业株式会社 2023-12-26 CN disclosed
CN-110505874-B Molecules having pesticidal utility, and intermediates, compositions and methods related thereto 科迪华农业科技有限责任公司 2023-09-26 CN disclosed
US-7005438-B2 Pharmaceutically active isoindoline derivatives CELGENE CORPORATION (US) 2006-02-28 US disclosed
US-6762195-B2 TREATING DISEASES MEDIATED BY TUMOR NECROSIS FACTOR; INHIBIT ANGIOGENESIS AND TREATMENT OF CANCER, INFLAMMATORY, AND AUTOIMMUNE DISEASES CELGENE CORPORATION 2004-07-13 US disclosed
US-20040122052-A1 Pharmaceutically active isoindoline derivatives CELGENE CORPORATION 2004-06-24 US disclosed
EP-1341537-A4 PHARMACEUTICALLY ACTIVE ISOINDOLINE DERIVATIVES CELGENE CORP (US) 2004-01-28 EP disclosed
EP-1341537-A2 PHARMACEUTICALLY ACTIVE ISOINDOLINE DERIVATIVES CELGENE CORPORATION (US) 2003-09-10 EP disclosed
US-20030069428-A1 Pharmaceutically active isoindoline derivatives MULLER GEORGE 2003-04-10 US disclosed
WO-2002094180-A2 PHARMACEUTICALLY ACTIVE ISOINDOLINE DERIVATIVES CELGENE CORPORATION (US) 2002-11-28 WO disclosed
US-6458810-B1 TREATMENT OF DISEASE STATES MEDIATED BY, TNF.ALPHA.. A TYPICAL EMBODIMENT IS TUMOR NECROSIS FACTOR FOR CANCER TREATMENT CELGENE CORPORATION 2002-10-01 US disclosed
EP-1086064-A2 DIRECTED COMBINATORIAL COMPOUND LIBRARY AND HIGH THROUGHPUT ASSAYS FOR SCREENING SAME Glycodesign Inc. (CA) 2001-03-28 EP disclosed
WO-1999064378-A2 DIRECTED COMBINATORIAL COMPOUND LIBRARY AND HIGH THROUGHPUT ASSAYS FOR SCREENING SAME GLYCODESIGN INC. (CA) 1999-12-16 WO disclosed